CHU de Strasbourg

The trials here

What the 31 trials at this site are about, from their registry records.

Conditions

• Multiple sclerosis4 trials
• Childhood cancers2 trials
• Colorectal cancer2 trials
• COPD2 trials
• Heart failure2 trials
• High blood pressure2 trials
• Mantle cell lymphoma2 trials
• Alzheimer disease1 trial
• Aortic stenosis1 trial
• Atrial fibrillation1 trial
• Brain aneurysm1 trial
• Cervical cancer1 trial
• and 11 more

Phase

• Phase 34 trials
• Phase 22 trials

Status

• Completed10 trials
• Recruiting8 trials
• Active, not recruiting6 trials
• Not yet recruiting6 trials
• Terminated1 trial

Lead sponsor

• University Hospital, Bordeaux5 trials
• The Lymphoma Academic Research Organisation3 trials
• University Hospital, Limoges3 trials
• Centre Hospitalier de PAU2 trials
• EDMUS Foundation2 trials
• and 13 more

Running trials

• Recruiting

  Determinants of Malignant Hypertension Onset and Related Target Organ Damages: the HAMA Biobank

  NCT06629363· Centre Hospitalier de PAU· Source

  Contact: Dominique STEPHAN

• Recruiting

  Stratification of Arrhythmic Risk and/or Heart Failure Risk in Patients With Hereditary Heart Disease

  NCT07257289· Nantes University Hospital· Source

  Contact: JESEL Laurence

• Not yet recruiting

  Imlifidase for Highly Sensitized Kidney Transplant Recipients With a posItive crossmAtch Against a Deceased Donor: Results of Kidney Transplantations Performed in Accordance to the French Guidelines.

  NCT07379957· University Hospital, Bordeaux· Source

  Contact: Sophie OHLMANN

• Not yet recruiting

  Interest of Preoperative Arteriography to Identify the Adamkiewicz Artery Before Surgery for Basi-thoracic Neuroblastic Tumors

  NCT06798532· Assistance Publique - Hôpitaux de Paris· Source

  Contact: Sarah MD Jannier

• Recruiting

  International Study of the SING IMT™ Prosthesis in Pseudophakic patiEnts With Stable Moderate to Profound Bilateral Central vIsion Impairment Due to adVancEd AMD / PERSPECTIVE Study

  NCT07164378· VisionCare, Inc.· Source

  Contact: Faustino Vidal Aroca

• Recruiting

  Trial Evaluating the Rate of Pneumothorax in Severe Emphysema Secondary to Endoscopic Volume Reduction With Two-stage ZEPHYR® Valves Versus Endoscopic Volume Reduction With One-stage ZEPHYR® Valves

  NCT06181357· University Hospital, Limoges· Source

  Contact: Romain KESSLER, MD

• Active, not recruiting

  Impact of Annual Versus Biannual Infusions of Ocrelizumab in Patients With Active MS,After 2 Years of Initial Treatment, on Freedom From Radiological Disease Activity at Two Years: a Multicenter Randomized Controlled Non-inferiority Trial

  NCT05999604· Phase 3· Fondation Ophtalmologique Adolphe de Rothschild· Source

• Recruiting

  Optimization of the Surgical Care Pathway for Kidney Tumors by Digitizing Perioperative Nursing Coordination (UroCCR 126)

  NCT06047600· University Hospital, Bordeaux· Source

  Contact: Hervé LANG, Pr.

• Not yet recruiting

  Evaluation of the Efficacy of Immunomodulatory Therapy in Case of Psychiatric Disorders With Proven Dysimmunity.

  NCT05946486· Phase 3· University Hospital, Bordeaux· Source

  Contact: Fabrice Berna

• Active, not recruiting

  Balloon-Expandable Versus Self-expanding Transcatheter Heart Valve for Treatment of Symptomatic Native Aortic Valve Stenosis (BEST)

  NCT05454150· University Hospital, Lille· Source

• Active, not recruiting

  OFSEP Very High Definition Cohort

  NCT05622643· EDMUS Foundation· Source

• Recruiting

  Hizentra® in Inflammatory Neuropathies - pHeNIx Study

  NCT04672733· CSL Behring· Source

  Contact: Trial Registration Coordinator

• Recruiting

  Identification of Dysglycemia With Continuous Glucose Monitoring to Assess Clinical Evolution in Cystic Fibrosis

  NCT05099939· Institut de Recherches Cliniques de Montreal· Source

  Contact: Laurence Kessler

• Recruiting

  French Colorectal ESD Cohort in Experts Centers

  NCT04592003· University Hospital, Limoges· Source

  Contact: Lucile LH HEROIN, Dr

• Recruiting

  A New Breath for Malignant Hypertension: Implementation of the HAMA Cohort

  NCT03755726· Centre Hospitalier de PAU· Source

  Contact: Dominique STEPHAN

• Recruiting

  Unruptured Cerebral Aneurysm: Prediction of Evolution

  NCT04578808· Nantes University Hospital· Source

  Contact: Raoul POP

• Active, not recruiting

  Evaluation of the Safety and Efficacy of TLD in Patients with COPD

  NCT03639051· Nuvaira, Inc.· Source

• Active, not recruiting

  Serum Neurofilament-light Chain and GFAP Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple Sclerosis

  NCT03981003· Centre Hospitalier Universitaire de Nīmes· Source

• Active, not recruiting

  OFSEP High Definition Cohort

  NCT03603457· EDMUS Foundation· Source

• Recruiting

  French National Database of Rare Dermatological Cancers

  NCT03210935· University Hospital, Lille· Source

  Contact: Dan Lipsker, MD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers2 recruiting
• High blood pressure2 recruiting
• Brain aneurysm1 recruiting
• Chronic kidney disease1 recruiting
• CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
• Colorectal cancer1 recruiting
• COPD1 recruiting
• Cystic fibrosis1 recruiting
• Heart failure1 recruiting
• Kidney cancer1 recruiting
• Macular degeneration1 recruiting
• Neuroblastoma1 recruiting

Closed trials

• Completed

  Deep Brain Stimulation for Parkinson's Disease: Probabilistic STN Targeting Under General Anaesthesia Without Micro-electrode Recordings vs Current Targeting Procedure

  NCT04884412· University Hospital, Bordeaux· Source

• Terminated

  Assessment of Quitting Versus Using Aspirin Therapy In Patients Treated With Oral Anticoagulation for Atrial Fibrillation or Other Indication With Stabilized Coronary Artery Disease

  NCT04217447· Phase 3· University Hospital, Brest· Source

• Completed

  Concordance and Accuracy of MRI in the Detection of Meningiomas: Optimizing Sequences With Low Doses of Gadolinium

  NCT04113395· Fondation Ophtalmologique Adolphe de Rothschild· Source

• Completed

  Long-term Follow-up of Cognitive and Functional Evolutions of Persons With Isolated Cognitive Complaints or Mild Cognitive Deficits

  NCT04111211· University Hospital, Bordeaux· Source

• Completed

  Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma

  NCT03458260· Phase 2· The Lymphoma Academic Research Organisation· Source

• Completed

  Study of the Therapeutic Response and Survival of Patients with Metastatic Colorectal Cancer (stage IV) and Treated According to the Guidelines of a Chemosensitivity Test, Oncogramme® (ONCOGRAM)

  NCT03133273· University Hospital, Limoges· Source

• Completed

  Quality of Sleep of Patients With Predominant Central Sleep Apnea Syndrome(SAS) Whose EF > 45% Treated by ASV

  NCT02835638· Société Française de Recherche et de Médecine du Sommeil· Source

• Completed

  Efficacy of Upfront and Maintenance Obinutuzumab in Mantle Cell Lymphoma Treated by DHAP and MRD Driven Maintenance

  NCT02896582· Phase 2· The Lymphoma Academic Research Organisation· Source

• Completed

  Registry of Translarna (Ataluren) in Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)

  NCT02369731· PTC Therapeutics· Source

• Completed

  R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCL

  NCT01865110· Phase 3· The Lymphoma Academic Research Organisation· Source

• Completed

  Radical Versus Simple Hysterectomy and Pelvic Node Dissection With Low-risk Early Stage Cervical Cancer

  NCT01658930· Canadian Cancer Trials Group· Source